Scribd
Upload
2K views

Innohep Syringe

This document provides instructions for preparing and administering syringes of innohep, including cleaning the injection site, preparing the syringe, injecting the medication, disposing of used syringes safely, and indications for use of innohep. The instructions include 12 numbered steps for administration and 6 numbered steps for disposal.

Uploaded by

Louie S. Zamuco
Copyright
© © All Rights Reserved
Available Formats
Download as PDF, TXT or read online on Scribd
2K views

Innohep Syringe

This document provides instructions for preparing and administering syringes of innohep, including cleaning the injection site, preparing the syringe, injecting the medication, disposing of used syringes safely, and indications for use of innohep. The instructions include 12 numbered steps for administration and 6 numbered steps for disposal.

Uploaded by

Louie S. Zamuco
Copyright
© © All Rights Reserved
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

Syringe Preparation

innohep® (tinzaparin) Prefilled Syringe*


Pr

& Administration1

1 • Always wash hands before you give your patient an 7 • If there is no need to adjust the dose, it is not necessary
injection. to remove the air bubble in the syringe before injecting.
• Gently wipe (do not rub) the patient’s skin around the • If dose adjustment IS required, prior to injection, hold the
injection site clean using an alcohol swab and let the syringe with the needle pointing up; tap gently, moving
skin air dry. the air bubble to the top of the syringe.

2 8
• Slowly push the plunger up to push the air bubble out.
• Open the storage tube by flipping the tab back and Top Edge Continue to slowly push the plunger up until the top
bending the coloured lid all the way back. (FILL LINE) edge of the rubber stopper reaches the line matching
the dose.

• Inject into the fatty tissue of the skin (subcutaneously)


at a 90° right angle.
3 9
• Remove the syringe and inspect the content of the • Hold a fold of skin gently between the thumb and
syringe before you use it. index finger. With the other hand, gently insert the
• Discard the syringe if the solution appears cloudy or has needle into the skin fold. Be careful not to inject into
particles. A clear to slightly yellow solution is fine to use. the muscle. Ensure the safety device is not in the way.
• Push the plunger all the way down and slowly inject
the dose into the fatty tissue of the skin. Wait a
4 10 few seconds for the solution to spread out. Gently
• Each innohep® syringe is equipped with a needle-trap™
remove the needle and then release the skin fold.
device (orange shield).2†
• Flip down the orange safety shield so that it is away from • The lower stomach is the preferred location to
the grey rubber cap. inject and is accessible by the patient (when they
are self-injecting).

5 11
• Twist and pull the grey rubber cap which protects the
needle. Pull it straight off, being careful not to bend • You can also inject the sides of the thigh or the
the needle. lower back or upper arm.
• Choose a different injection site next time (ie. move
from the left to the right side of the stomach).
6 12
• Do NOT remove the grey rubber cap before flipping down Caution: Avoid the belly button area.
the orange safety shield first.
* Please consult Product Monograph for complete dosing and administration instructions.
† The Needle Trap safety device has won several awards worldwide, including: World Label Award
2010; World Packaging Organisation Worldstar for Packaging; FINAT; Deutschland Land der
Ideen 2011; German Packaging Award 2008; Materialica Product Design Award 2011; and TLM
Innovator Award 2011.
Syringe
innohep® (tinzaparin) Prefilled Syringe*
Pr

Disposal1

1 • Using the edge of a hard surface, bring the orange safety 4


shield up from underneath and back to its original
location. Position the needle into the small grooves in
the orange shield.
• Deposit innohep® syringe back into the innohep®
storage tube, with needle facing down, then push the
cap down firmly until the tab clicks securely into the slot
2 5 OR place the syringe directly into the sharps container
• Fully lock the needle into the orange shield by pressing and the storage tube in a recycling container.
down firmly on the syringe at a 45-90 degree angle
against a hard surface until the needle is bent as shown
in the photo. You should hear an audible click.

• The innohep® empty plastic storage tube can be


3 • Do NOT use your finger (or the patient’s mattress or 6 recycled in provinces that accept it.
other semi-hard surface) to try to lock the needle into
the orange shield.
• Do NOT touch the syringe or try and pull the needle
out after the needle has been locked into the orange
safety shield.

innohep® (tinzaparin sodium) is indicated for:1


• The treatment of deep vein thrombosis and/or pulmonary embolism.
Treatment with innohep® should be continued until therapeutic oral anticoagulant effect has been achieved (INR 2.0 to 3.0), usually within 5 days. The average duration of innohep® administration
is 7 days. Published clinical data are available documenting extended treatment with innohep® 175 IU/kg once daily for 3-6 months in patients with cancer associated thrombosis (CAT). The use
of innohep® beyond 6 months must be evaluated in the absence of clinical data.*, Δ

For more information Δ The recommended dosage is 175 anti-Xa IU/kg body weight given subcutaneously once daily at the same time every day.
The recommended maximum daily dose is 18,000 anti-Xa IU/day. Concomitant treatment with oral anticoagulants (vitamin K
Please consult the product monograph for innohep® at www.leo-pharma.ca/innohep_pm for important antagonists) is usually started immediately.
information relating to contraindications, warnings, precautions, adverse reactions, interactions, dosing, References
and conditions of clinical use. 1. Current innohep® product monograph. LEO Pharma Inc.
2. Schreiner MediPharm. Award winning idea. Accessed February 2017 at: http://www.needletrap.com/3/needle-trap-pharma/awards/.
The product monograph is also available at www.leo-pharma.ca and by contacting Medical Information ® Registered trademark of LEO Pharma A/S used under license and distributed by LEO Pharma Inc., 123 Commerce Valley Dr. E., Suite 400. Thornhill,
at LEO Pharma Inc., at 1-800-263-4218. Ontario L3T 7W8

Pr

www.leo-pharma.ca MAT-18521

You might also like